NOTICE: Monthly Manufacturer Call Status, Current Open Comment Opportunities
Relevant to: All Drug Manufacturers and Other Interested Parties
February 2024 Memos
2024 Risk Score Reruns for Purposes of Payment Recovery
Relevant to: All Medicare Advantage Organizations, PACE Organizations, MedicareMedicaid Plans, Section 1833 Cost Contractors and Section 1876 Cost
Contractors, and Demonstrations
Completion of the Coverage Gap Discount Reconciliation for Benefit Year 2022
Relevant to: All Part D Sponsors
Medicare Advantage/Prescription Drug System (MARx) March 2024 Payment – INFORMATION
Relevant to: All Medicare Advantage Organizations, Prescription Drug Plans,
Cost Plans, PACE Organizations, and Demonstrations
Promising Practices: Opioid Educational Sessions
Relevant to: All Medicare Advantage Organizations (MAOs) and Prescription Drug Plan
Sponsors (PDPs)
Contract Year 2025 MA and Part D Bid Pricing Tool Beta Testing
Relevant to: Medicare Advantage & Prescription Drug Plan Sponsors and Certifying Actuaries
2023 Call Center Monitoring Performance Metrics for Timeliness Study, Quarter 4
Relevant to: All Medicare Advantage, Prescription Drug Plan, and Demonstration Organizations
Frequently Asked Questions related to Coverage Criteria and Utilization Management Requirements in CMS Final Rule (CMS-4201-F)
Relevant to: All Medicare Advantage Organizations and Medicare-Medicaid Plans
Release of 2024 MIPS Payment Adjustment Data File
Relevant to: All Medicare Advantage, Cost, PACE Organizations, and Demonstration Organizations Systems Staff